Evaluation of reactive hyperemia and ischemia-reperfusion using the EndoPAT

Withdrawn

• Conditions: 10047079; Endothelial function

• Registration Number: NL-OMON33369
• Lead Sponsor: Centre for Human Drug Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

Be at least 18 years of age;
Able to keep to the diet and other restrictions and instructions as listed in the protocol.
Able and willing to sign the Informed consent form.

Exclusion Criteria

In general: any clinically significant disorder (current or past medical history or physical examination) that in the opinion of the investigator precludes study participation.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Heart rate variability, the augmentation index and hyperemia index. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>na</p><br>